𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel therapeutic targets for nonalcoholic fatty liver disease

✍ Scribed by Eguchi, Akiko; Povero, Davide; Alkhouri, Naim; Feldstein, Ariel E

Book ID
120401459
Publisher
Informa plc
Year
2013
Tongue
English
Weight
335 KB
Volume
17
Category
Article
ISSN
1472-8222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hypouricemic therapy: A novel potential
Hypouricemic therapy: A novel potential therapeutic option for nonalcoholic fatty liver disease
✍ Cheng-Fu Xu; Chao-Hui Yu; Lei Xu; Xiao-Ying Sa; You-Ming Li πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 411 KB πŸ‘ 1 views

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no

Nonalcoholic fatty liver disease after l
Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples